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Laparoscopic Adrenalectomy is Feasible for 
Large Adrenal Masses > 6 cm
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OBJECTIVE: Laparoscopic adrenalectomy (LA) has become the established procedure for adrenal masses
less than 6 cm. The role of LA for large adrenal masses is well defined to a lesser extent.
METHODS: Thirty-six LAs were performed in 32 patients (including four patients with single stage bilat-
eral adrenalectomies) over a period of 3 years, from May 2002 to 2005. Patients were divided into two
groups based on the tumour size, i.e. masses less than 6 cm (group I) and masses 6 cm or more (group II).
The results with respect to mean (95% confidence interval) operative time, blood loss, postoperative
course and complications were compared.
RESULTS: Group II included 11 LAs performed in 10 patients including one bilateral LA for bilateral
phaeochromocytomas in multiple endocrine neoplasia 2A. The mean size (± standard deviation) of
masses was 8 cm (± 1.47). In comparison, 22 patients in group I underwent 25 adrenalectomies (including
three bilateral single stage procedures for Cushing’s syndrome). The mean size of masses was 4.1 cm
(± 1.27). There were eight and six phaeochromocytomas in groups I and II, respectively. By comparing
groups I and II, only minimal increase in blood loss and operating time was noted with no significant 
difference in hospital stay and morbidity. Two cases required conversion to hand assistance towards the
end of the procedure in view of their large size.
CONCLUSION: LA is the procedure of choice for small adrenal masses but is also feasible for large func-
tioning and nonfunctioning adrenal masses with equally good results. Even bilateral large functioning
tumours can be treated safely by LA in a single stage when sufficient experience with the procedure is
attained. [Asian J Surg 2007;30(1):52–6]
Key Words: adrenal gland neoplasm, adrenalectomy, laparoscopy, phaeochromocytoma
Introduction
Laparoscopic adrenalectomy (LA) is the established gold
standard procedure for adrenal masses with all the inher-
ent advantages of minimally invasive surgery.1,2 There is
no recommended consensus on the maximum tumour
size that can safely be removed laparoscopically. The aim
of our study was to assess the feasibility of LA for adrenal
masses ≥ 6 cm in size and whether the larger size causes
any significant increase in morbidity, technical difficulty
and complications.
Patients and methods
Data were entered prospectively for 32 patients who under-
went 36 LAs between May 2002 and 2005 at our depart-
ment. Of the 32 patients, 10 patients had masses ≥ 6 cm
(group II) and 22 patients had masses < 6 cm (group I). 
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All patients underwent preoperative biochemical eval-
uation including 24-hour urinary vanillylmandelic acid
(VMA), metanephrines and cortisol. Imaging was done
with contrast-enhanced computed tomography (CT).
Magnetic resonance imaging, meta-iodobenzylguanidine
and iodonorcholesterol scanning were performed in
selected patients. In cases where biochemical investiga-
tions indicated the mass to be phaeochromocytoma, ade-
quate alpha blockade and volume replenishment were
performed preoperatively.
A single surgeon performed all the laparoscopic
adrenalectomies using the anterolateral transperitoneal
approach. Three ports were used on the left and four on
the right side with the patient in lateral kidney position.
A 10 mm camera port was inserted by an open technique
at a site 2 cm above the umbilicus at the lateral border of
rectus sheath. Two working ports were employed. One
10 mm port was placed in the iliac area 2 inches above and
medial to the anterior superior iliac spine and one 5 mm
port was placed subcostally in the midclavicular line. An
additional 5 mm liver retraction port was used for the
right side in the epigastrium. Carbon dioxide was used for
insufflation and pneumoperitoneum was maintained
keeping a pressure of 12–14 mmHg.
On the left side, early control of the adrenal vein was
attained after medial mobilization of the colon, spleen
and pancreas. On the right side, the right lobe of the liver
was mobilized and inferior vena cava exposed to approach
the adrenal vein. After control of the adrenal vein, the
gland was dissected free using the Harmonic scalpelTM
(Ethicon, Johnson and Johnson, Cincinnati, OH, USA).
Specimens were retrieved after extending the iliac port
incisions. In two left-sided masses, a terminal hand assist
was employed (no special hand port device was necessary)
through a midline supraumbilical 7 cm incision. This
same incision was used to extract the specimen. In one
woman who underwent single stage bilateral LA for large
bilateral phaeochromocytomas, a lower midline incision
through her previous tubectomy scar was used to extract
the specimens. The simultaneous bilateral LA in both
groups I and II was performed by the anterolateral
transperitoneal approach with the patient in the lateral
decubitus position. The patient was repositioned and
draped in the opposite lateral decubitus position after
completing one side. All specimens were removed intact
without morcellation in an endo-catch bag. The mean
(95% confidence interval [CI]) operating time, mean blood
loss and postoperative course in the two groups were
assessed. Intraoperative haemodynamic alteration was
defined as a rise in systolic blood pressure by 30% and/or
diastolic blood pressure by 10% of the baseline at any time
from positioning, induction, creating pneumoperitoneum
and handling the tumour. A fall in blood pressure by the
same margins after removal of the tumour was also con-
sidered as haemodynamic alteration.
Results
A total of 32 patients underwent 36 LAs during the study
period. This included four cases of single stage bilateral
LA. None of the LA was converted to open surgery.
Group II included 10 patients (11 LAs) with masses
≥ 6 cm (one patient underwent bilateral LA for large bilat-
eral phaeochromocytomas in multiple endocrine neopla-
sia [MEN] 2A syndrome). This group comprised five
males and five females, with a mean age (± standard devi-
ation) of 42.8 years (± 10.65). Five tumours were left-sided,
four right-sided and one bilateral. The mean size of the
masses in group II was 8 cm (± 1.47). The indications for
surgery in group II were pain abdomen, large inciden-
taloma and preoperative diagnosis of phaeochromocy-
toma (Table 1). Postoperative histopathology of the 11
tumours revealed six phaeochromocytomas (one bilat-
eral), two ganglioneuromas and one each of soft tissue
tumour (leiyomyoma), tuberculosis and myelolipoma.
Twenty-two patients (25 LAs) in group I had a mean age of
33.6 years (±15.02). This group was composed of 16 females
and six males, with 10 tumours on the right, nine on the left
and three bilateral. The mean size of the tumours in this
group was 4.1 cm (± 1.27). Histopathology of the 25 speci-
mens showed eight phaeochromocytoma, six Cushing’s, six
Conn’s, two adenomata, one each with hyperplasia, gan-
glioneuroma and a normal adrenal. All except one were
benign. The large phaeochromocytoma of 11 cm was
reported as malignant, in view of the size and vascular inva-
sion. The normal gland was removed in a teenaged boy
with uncontrolled hypertension needing three drugs. His
urinary VMA was elevated and CT scan was misinter-
preted as a left adrenal mass, which in retrospect was
probably just a very prominent splenic notch.
The mean (95% CI—lower and upper values) operative
time, blood loss and hospital stay for group II was 142.7
minutes (103, 182), 105.9 mL (34.4, 177.4) and 4.1 days
(3.12, 5.08), respectively. Group I had a mean (95% CI)
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operating time, blood loss and hospital stay of 113.9 min-
utes (85.25, 142.55), 40 mL (29.04, 50.96) and 3.8 days
(3.37, 4.23), respectively.
Two of the larger left-sided masses that were greater
than 8 cm were converted to hand assistance towards the
end of the procedure to facilitate dissection and retrieval.
One was a large vascular phaeochromocytoma (11 cm) and
the second was a large tuberculous adrenal with enlarged
nodes. A 7 cm midline incision was made in the epigastrium
towards the end of the procedure. The left hand of the oper-
ating surgeon was then inserted to snugly fit the incision
at the wrist. The specimen was retrieved through the same
incision. No special hand port device was employed as this
part of the operation lasted for less than 10 minutes and the
minimal gas leak was reduced by manually compressing
around the incision. One woman with MEN 2A syndrome
underwent single stage bilateral LA for phaeochromocy-
tomas measuring more than 8.5 cm on each side. In her case,
the specimens were retrieved through an infraumbilical
midline incision through the scar of previous tubectomy.
In one of the patients with an 8 cm right-sided mass, a
simultaneous laparoscopic cholecystectomy for calculus
cholecystitis was performed. Eighty-three percent (5/6) 
of group II and 50% (4/8) of group I patients with phaeo-
chromocytoma had intraoperative rise in blood pressure.
Irrespective of their size, these could be managed easily. All
the phaeochromocytomas had a fall in blood pressure
irrespective of group or size following the removal of the
tumour; this was managed by volume expansion. The over-
all complication rate in group II was 30% (3/10). This
included intraoperative blood loss needing transfusion
(n = 1), minor wound infection (n = 1) and pulmonary
oedema (n = 1). Blood loss occurred in one patient with a
tuberculous adrenal adherent to surrounding structures.
One patient with phaeochromocytoma developed pul-
monary oedema and needed postoperative ventilation for
8 hours. One patient with a large myelolipoma had a minor
infection of the incision site through which the specimen
Table 1A. Demographics of 10 patients with adrenal mass ≥ 6 cm
S. no. Age (yr) Sex Side Size (cm) Indication for surgery
1 48 F Right 6 Incidentaloma
2 28 M Left 6.7 Pain abdomen
3 64 M Right 8 Evaluation of hypertension
4 32 M Left 11 Phaeochromocytoma
5 47 M Left 7 Incidentaloma
6 37 F Bilateral 9 Phaeochromocytoma
7 40 F Left 8 Phaeochromocytoma
8 49 F Left 9 Pain abdomen
9 34 F Right 6.5 Phaeochromocytoma
10 49 M Right 9 Large myelolipoma
Table 1B. Operative details of 10 patients with adrenal mass ≥ 6 cm
S. no. Histopathology Operating time (min) Blood loss (mL) Hospital stay (d) Complications
1 Phaeo 240 300 4 Blood transfusion
2 Ganglioneuroma 90 50 2 None
3 Leiyomyoma 240 20 5 None
4 Phaeo 210 250 8 Pulmonary oedema
5 Ganglioneuroma 120 50 4 None
6 Phaeo 220 100 3 None
7 Phaeo 90 25 4 None
8 Tuberculosis 180 300 4 None
9 Phaeo 120 50 4 None
10 Myelolipoma 60 20 3 Minor wound infection
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was retrieved. In group I, only two patients had minor com-
plications of shoulder tip pain and subhepatic collection
that resolved spontaneously.
In both groups, patients were ambulant, tube free and
able to tolerate a fluid diet on the 1st postoperative day.
Discussion
Since the first description of the technique by Gagner
et al3 in 1992, LA has become the gold standard procedure
for all types of adrenal pathologies. The indications for
adrenalectomy broadly include all functioning masses
irrespective of size and nonfunctioning adrenal masses
> 4 cm. The absolute contraindications for LA are large
adrenocortical carcinomas with tumour invasion of 
adjacent structure, metastatic phaeochromocytomas to
para-aortic lymph nodes, phaeochromocytomas during
pregnancy, unacceptable cardiopulmonary disease and
untreated bleeding diathesis.2,4 However, large size alone
is not an absolute contraindication.2
Although a variety of laparoscopic approaches have
been described, our experience has been exclusively with the
anterolateral transperitoneal approach. This is also the most
commonly practiced approach in most published series.5–7
We have found this approach advantageous because of the
wide exposure obtained, especially for large lesions. Gravity
also aids to keep mobilized viscera away from the field. In
two cases, we were able to do additional intra-abdominal
procedures (cholecystectomy and deroofing of renal cyst)
at the same time. Although proponents of the retroperi-
toneal endoscopic adrenalectomy also claim advantages,
the approach is not useful for large adrenal masses.7–9
To date, no consensus has been reached on the maxi-
mum lesion size that can be removed laparoscopically.
Gagner4 reported removal of a 15 cm adrenal mass by LA.
Adrenal masses > 6 cm are considered potentially malig-
nant and in general have not been considered suitable for
LA. Recent large series have reported successful outcomes
with LA for large masses. Except anecdotally the upper
limit for size has been 12 cm (Table 2).
The concerns with regard to LA for large lesions
(> 6 cm) are the likelihood of lesions being malignant and
the possibility of inadequate removal and inability to
remove adjacent organs. An increased risk of local and
distant recurrence has been described.10–12 Analysis of
results by various authors performing LA for known and
suspected malignant adrenal masses has shown that local
and systemic recurrences do occur, although no port site
recurrence has been reported.13,14 Interestingly, with regard
to the recurrence rate, laparoscopic resection offers short-
term oncological results comparable to open surgery.14
Technically, LA for large masses needs adequate experi-
ence. In our series, we noted that with increasing experience,
operating times continue to decrease. The mean operat-
ing time for the initial 20 adrenal units was 141.7 minutes
as compared to the mean operating time of 98.9 minutes
for the next 16 units (data not shown). In subsequent
cases performed at our centre that are not included in this
study, the operating time has further shortened, indicating
that there is a definite learning curve for LA. Our series
correlates with other series of LA for large masses which
have reported a mean operating period of 129–205 minutes,
blood loss of 100–400 mL and conversion rate of 0–11%
mainly due to malignant invasion. The overall complication
Table 2. Laparoscopic adrenalectomy in large tumours
Study n Approach
Mean Operating Blood Conversions Complications Hospital
size (cm) time (min) loss (mL) (%) (%) stay (d)
Henry et al9 19 LTA 7 (6–9) N/A N/A 11 0 N/A
Kazaryan et al18 12 LTA 5.8 (3.5–11) 165 125 0 0 3
Valeri et al13 6 LTA 2.5–6 160 260 0 0 4
Kebebew et al14 23 LTA, REA 5.1 (1.5–12) 166 N/A 4 13 2.75
MacGillivray et al15 12 LTA 8.2 (6–12) 190 100 0 42 2
Hobart et al16 14 LTA, REA 8 205 400 14 21 2.4
Heinford et al17 11 LTA, REA 5.9 (1.8–12) 181 138 9 9 2.3
This study 11 LTA 8 (6–11) 142.7 105.9 2 THA 30* 4.1
*One haemorrhage, pulmonary oedema and wound infection each. n = total number of patients; LTA = lateral transperitoneal approach;
REA = retroperitoneal endoscopic adrenalectomy; N/A = data not available; THA = terminal hand assist. Note: Values in parentheses are 
the range.
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rate was 0–42%.9,13–18 Although we had an overall compli-
cation rate of 30% in group II, it was only 9% in group I.
This was not statistically significant using Fisher’s exact
test. Bleeding requiring transfusion occurred in a patient
who had adhesions to surrounding structures. Terminal
hand assist is an option to be kept in mind while perform-
ing LA for larger masses and was required in two patients
in our series. There were no conversions to open surgery
or mortality.
LA for large adrenal masses is safe and feasible. The
lateral transperitoneal approach in such cases offers the
advantage of wide exposure and large working space. 
This approach can be used to offer LA in a single stage 
to patients with large bilateral functioning masses; with
increased experience, the mass size alone does not become
the limiting factor. The maximum accepted size contin-
ues to be debated, although it seems prudent not to advo-
cate LA for masses > 12 cm in view of the technical
difficulty, longer operating time, increased blood loss,
more complications and potential for malignancy with
adjacent organ involvement. The employment of terminal
hand assist as an option increases the effectiveness of LA
for large and adherent adrenal masses.
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